23andMe's special committee of independent directors on Monday rejected CEO Anne Wojcicki's proposal to take the ...

The latest plan by 23andMe co-founder and CEO Anne Wojcicki to acquire the genetic testing company was rejected by a special ...

Wojcicki and New Mountain have offered to acquire all of 23andMe's outstanding shares in cash for $2.53 per share, or an equity value of approximately $74.7 million. The company's stock closed at ...

The Special Committee has reviewed Ms. Wojcicki’s acquisition proposal in consultation with its financial and legal advisors, and has unanimously determined to reject the proposal. Moelis & Company ...

Experts say the CEO’s second attempt to buy back the troubled DNA startup comes with a slew of corporate governance red flags ...

23andMe's special committee of independent directors on Monday rejected CEO Anne Wojcicki's proposal ... to a filing with the U.S. Securities and Exchange Commission. The stock plunged 33% on ...

The special committee of the board of directors of 23andMe (ME) confirmed receipt of a non-binding proposal from Anne Wojcicki, CEO, ...

23andMe CEO Anne Wojcicki and New Mountain Capital ... according to a Friday filing with the U.S. Securities and Exchange Commission. Wojcicki and New Mountain have offered to acquire all of ...